Citation Impact
Citing Papers
Comparative lesion sequencing provides insights into tumor evolution
2008
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Molecular mechanisms mediating metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer
1993
Prognostic Impact of Serum Calcitonin and Carcinoembryonic Antigen Doubling-Times in Patients with Medullary Thyroid Carcinoma
2005
Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer
2005
Usefulness of Analytical CEA Doubling Time and Half-life Time for Overlooked Synchronous Metastases in Colorectal Carcinoma
2002
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis
1996 Standout
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Clinical use of tumor markers in oncology
1991
Emerging Biological Principles of Metastasis
2017 Standout
Circulating mutant DNA to assess tumor dynamics
2008 Standout
The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro‐drugs used in the management of ulcerative colitis
2002
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
TGFβ in Cancer
2008 Standout
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
2001
The hallmarks of cancer
2012 Standout
Prostate Cancer
2003 StandoutNobel
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Clonal evolution in cancer
2012 StandoutNature
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
1996 Standout
Crypt stem cells as the cells-of-origin of intestinal cancer
2008 StandoutNature
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
The Use of Serologic Tumor Markers in Gastrointestinal Malignancies
1994
Diagnostic and Prognostic Values of Carcinoembryonic Antigen in Medullary Carcinoma of the Thyroid*
1984
Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.
1992
Intraoperative radioimmunodetection of colorectal tumor with a hand-held radiation detector
1985
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
2010
Cancer Genome Landscapes
2013 StandoutScience
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
1999 Standout
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
1997 Standout
Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid: A randomized multicenter study
1986
Resection of colorectal liver metastases
1995 Standout
Works of E. Stumpf being referenced
Carcinoembryonic antigen follow‐up and selection of patients for second‐look operation in management of gastrointestinal carcinoma
1978
Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine, in man
1983
Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma
1981
Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer
1985
Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancer
1985
Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer
1978
Are circulating CEA immune complexes a prognostic marker in patients with carcinoma of the gastrointestinal tract?
1980
Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer
1982